OGN

Organon Stock Analysis

AI Rating

Fair
  • Quality7/10
  • Growth 0/10
  • Value 4/10
Organon sales and earnings growth
OGN Growth
Low
  • Revenue Y/Y -2.08%
  • EPS Y/Y -67.70%
  • FCF Y/Y -12.42%
Organon gross and profit margin trends
OGN Profitability
Neutral
  • Gross margin 52.80%
  • EPS margin 4.00%
  • ROIC 5Y 9.77%
Organon recent dividend growth
OGN Dividends
  • Dividend yield 0.60%
  • Growth 3Y -73.28%
  • Payout ratio 9%
Organon net debt vs free cash flow
OGN Risk
Poor
  • Debt / Equity 9.5
  • Debt / FCF 10.9
  • Interest coverage 2.1

Organon stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

↗ More Drug Manufacturers - General stocks